Stay updated on Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added study locations (Andalusia, Barcelona, Madrid, Valencia) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure section and its v3.3.2 reference.
    Difference
    0.6%
    Check dated 2025-12-22T22:31:34.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page, indicating a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:41:39.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces the previous v3.2.0 label on the page.
    Difference
    0.1%
    Check dated 2025-11-24T11:09:59.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Removed the government funding status notice warning about potential delays and outdated information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:10:00.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The update is non-substantive: the Study Record Dates last update posted date is 2025-05-14; core content such as eligibility, outcomes, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T00:47:34.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T07:17:35.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.